Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-075482
Filing Date
2025-05-20
Accepted
2025-05-20 19:34:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6681
2 EX-99.1 ck0000000000-ex99_1.pdf EX-99.1 40220
  Complete submission text file 0000950170-25-075482.txt   64261
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Subject) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94156 | Film No.: 25970552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12/F, BUILDING D, NO. 198 QIDI ROAD, HIPARK, XIAOSHAN DISTRICT HANGZHOU ZHEJIANG China 311200
Business Address 12/F, BUILDING D, NO. 198 QIDI ROAD, HIPARK, XIAOSHAN DISTRICT HANGZHOU ZHEJIANG China 311200 (86)57185389730
AP11 Ltd (Filed by) CIK: 0002069316 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SCHEDULE 13G